UnitedHealth Group Incorporated Net Change in Cash
UnitedHealth Group Incorporated (UNH) reported Net Change in Cash of $4.22 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-10
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $3.64B, a 32.73% decline year-over-year.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $5.41B, a 80.95% increase year-over-year.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $2.99B, a 83.90% decline year-over-year.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $18.55B, a 351.62% increase year-over-year.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$947.00M.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$115.00M, a 105.58% decline from fiscal 2023.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $2.06B, a 3.62% increase from fiscal 2022.
- UnitedHealth Group Incorporated cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $1.99B, a 55.32% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.22B 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | $3.64B 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$947.00M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $1.90B 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | $3.28B 10-Q · filed 2026-08-10 | |||
| 2025-03-31 | $5.41B 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | -$115.00M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $6.97B 10-Q · filed 2025-10-28 | |||
| 2024-06-30 | $859.00M 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | $2.99B 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $2.06B 10-K · filed 2026-03-02 | |||
| 2023-09-30 | $15.55B 10-Q · filed 2024-11-04 | |||
| 2023-06-30 | $18.45B 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | $18.55B 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $1.99B 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $17.47B 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | $3.24B 10-Q · filed 2023-08-02 | |||
| 2022-03-31 | $4.11B 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $4.45B 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $4.16B 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | $2.91B 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | $3.03B 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $5.94B 10-K · filed 2023-02-24 | |||
| 2020-09-30 | $6.57B 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | $11.34B 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | $10.58B 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $119.00M 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $1.50B 10-Q · filed 2020-11-02 | |||
| 2019-06-30 | $2.88B 10-Q · filed 2020-08-03 | |||
| 2019-03-31 | $1.54B 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | -$1.11B 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B |